The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-(5-((9-(4-nitrobenzyl)-9H-carbazol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid ID: ALA4210895
PubChem CID: 145966656
Max Phase: Preclinical
Molecular Formula: C25H17N3O5S2
Molecular Weight: 503.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CN1C(=O)/C(=C/c2ccc3c(c2)c2ccccc2n3Cc2ccc([N+](=O)[O-])cc2)SC1=S
Standard InChI: InChI=1S/C25H17N3O5S2/c29-23(30)14-27-24(31)22(35-25(27)34)12-16-7-10-21-19(11-16)18-3-1-2-4-20(18)26(21)13-15-5-8-17(9-6-15)28(32)33/h1-12H,13-14H2,(H,29,30)/b22-12-
Standard InChI Key: HHYQWBHIJNKKAM-UUYOSTAYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
2.6029 -12.7160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6017 -13.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3098 -13.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3080 -12.3071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0166 -12.7124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0214 -13.5310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8014 -13.7794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7937 -12.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2744 -13.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0825 -13.0245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4109 -12.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9251 -11.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1188 -11.7127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0606 -14.5544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8614 -14.7175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1164 -15.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9163 -15.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4588 -15.0418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1958 -14.2636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3965 -14.1041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2516 -10.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0636 -10.7801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6136 -11.3816 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.3575 -11.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2656 -10.2313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4649 -10.0679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1257 -9.3244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0684 -11.4463 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.8685 -9.6796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6477 -9.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2506 -9.3742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8240 -10.7238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2633 -15.2051 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8041 -14.5925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5235 -15.9798 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
7 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
26 27 2 0
24 28 2 0
25 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
33 34 2 0
33 35 1 0
18 33 1 0
M CHG 2 33 1 35 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 503.56Molecular Weight (Monoisotopic): 503.0610AlogP: 5.04#Rotatable Bonds: 6Polar Surface Area: 105.68Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.90CX Basic pKa: ┄CX LogP: 5.45CX LogD: 2.23Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.17Np Likeness Score: -1.44
References 1. Jiang H, Zhang WJ, Li PH, Wang J, Dong CZ, Zhang K, Chen HX, Du ZY.. (2018) Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors., 28 (8): [PMID:29545100 ] [10.1016/j.bmcl.2018.03.017 ]